Related references
Note: Only part of the references are listed.High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease
David W. Denning et al.
CLINICAL INFECTIOUS DISEASES (2011)
Current perspectives on echinocandin class drugs
David S. Perlin
FUTURE MICROBIOLOGY (2011)
Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens
P. Lewis White et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Echinocandin-Resistant Candida: Molecular Methods and Phenotypes
David S. Perlin
CURRENT FUNGAL INFECTION REPORTS (2011)
Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The radiological spectrum of pulmonary aspergillosis
R Greene
MEDICAL MYCOLOGY (2005)
Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients
J Maertens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: Variables that affect performance
KA Marr et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
β-D-glucan as a diagnostic adjunct for invasive fungal infections:: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome
Z Odabasi et al.
CLINICAL INFECTIOUS DISEASES (2004)
Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients
N Singh et al.
CLINICAL INFECTIOUS DISEASES (2003)
Share Paper
